Detransitioner Says Gender Procedures at Age 14 Left Her With Permanent, Life-Altering Injuries
Why It Matters
The debate over pediatric gender transition procedures has increasingly centered on the long-term medical consequences for minors who later regret those interventions. One young woman is now speaking publicly about the lasting physical damage she says resulted from hormone treatment and surgery she received beginning at age 14, adding a personal account to a national policy conversation that has intensified in recent years.
What Happened
Claire Abernathy, now 21, says she was prescribed testosterone one week after her 14th birthday and underwent a double mastectomy eight months later. She describes having disclosed a history of childhood sexual abuse to her medical providers before the procedures began — information she says did not prompt clinicians to pursue psychological alternatives before moving forward with irreversible interventions.
Three separate clinicians approved her transition, she says, without what she characterizes as adequate exploration of whether trauma, rather than a stable gender identity, was driving her distress. Abernathy says she has since stopped taking testosterone and identifies as a woman, but that the physical effects of her treatment cannot be reversed.
The Injuries She Describes
Abernathy details a range of ongoing medical complications she attributes to testosterone exposure and surgical procedures during adolescence. These include severe urological dysfunction — at times requiring adult incontinence products — vaginal atrophy, chronic pelvic pain, and persistent discomfort she says has not diminished five years after discontinuing testosterone.
She also describes lasting damage to her voice, which she says prevented her from continuing in choir and theater, activities central to her identity before her transition. Vocal strain and an inability to project properly now affect her daily life, she says.
Her surgical complications included tissue death and open wounds following a “drains-free” mastectomy technique. She says she was left with permanent nerve damage and has lost the ability to breastfeed any future children — a consequence she describes as growing heavier with time.
By the Numbers
- Age 14: Abernathy’s age when testosterone was first prescribed
- 8 months: Time between her first hormone prescription and her mastectomy
- 3: Number of clinicians who signed off on her transition without, she says, addressing the underlying trauma she disclosed
- 5 years: Duration since she stopped taking testosterone, with no resolution of certain physical complications
- 21: Her current age as she speaks publicly about the outcomes
Zoom Out
Abernathy’s account is part of a broader and growing detransitioner movement in which individuals — many of them women who began transition as adolescents — are publicly describing negative medical outcomes. Their accounts have become central to legislative and regulatory debates in multiple states and at the federal level over the appropriate standard of care for minors experiencing gender dysphoria.
Several European countries, including the United Kingdom and Sweden, have substantially restricted youth gender transition procedures following government-commissioned reviews that found insufficient evidence supporting their long-term benefit and raised concerns about irreversible harm. In the United States, over two dozen states have enacted laws restricting or banning such procedures for minors, and federal policy under the current administration has moved in a similar direction. Debates over how healthcare systems handle treatment authorization and patient protections have become intertwined with the broader discussion of medical oversight in this area.
Proponents of pediatric gender-affirming care maintain that access to transition-related treatment reduces suicide risk and improves mental health outcomes for adolescents with gender dysphoria. Abernathy directly contests that framing, saying her own distress was rooted in trauma and that medical providers used the prospect of suicidality to justify prescribing hormones rather than pursuing therapeutic alternatives.
What’s Next
Abernathy says she is sharing her account publicly to press for changes in how the medical system evaluates and treats adolescents presenting with gender dysphoria — specifically calling for greater scrutiny of trauma histories before irreversible interventions are approved.
Congress is currently weighing federal standards for pediatric care in this area, and the administration has already taken executive action restricting the use of federal funding for transition procedures on minors. Legal challenges to state-level restrictions remain active in multiple federal circuits, and the Supreme Court’s ruling in a related case earlier this year opened the door for broader state authority to regulate such procedures.